EUVIMEDEUVIMED entdecken
Crossref

A longitudinal analysis of haemoglobin levels and major cardiovascular events

Lisa Le Gall, Natalia Alencar de Pinho iD, Jérôme Harambat, Christian Combe iD, Tilman B Drüeke, Gabriel Choukroun, Denis Fouque, Antoine Barbieri, Luc Frimat, Christian Jacquelinet, Maurice Laville, Sophie Liabeuf iD und 7 weitere

Nephrology Dialysis Transplantation · 2025

DOI: 10.1093/ndt/gfaf221 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Nephrology Dialysis Transplantation, 2025. Verfasst von Lisa Le Gall und 18 weiteren Autor:innen. Beteiligte Einrichtung: Univ. Bordeaux, INSERM, BPH, U1219, CIC 1401, F-33000 Bordeaux, France. Hauptthemen laut MEDLINE: Hemoglobins, Cardiovascular Diseases, Renal Insufficiency, Chronic, Anemia. Die Arbeit nennt 55 Literaturangaben. Gefördert von: Agence Nationale de la Recherche, GlaxoSmithKline, Boehringer Ingelheim France.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background and hypothesis The standard approach to anaemia in non-dialysis chronic kidney disease (CKD) does not account for potential age- or sex-specific related risks. We assessed differences in the association between haemoglobin and major cardiovascular events (MACE+) in men and women with CKD, by age groups.

Methods

Using 5-year longitudinal data from the Chronic Kidney Disease-Renal Epidemiology and Information Network (CKD-REIN) cohort, we studied patients with CKD stage 2–5 not treated with erythropoiesis-stimulating agents (ESA). The main outcome was MACE+, defined as cardiovascular death, myocardial infarction, stroke or hospitalization for acute heart failure. Competing events were initiation of kidney replacement therapy and non-cardiovascular death. In each of the four predefined subgroups by sex and age (≤70 versus >70 years at baseline), we estimated hazard ratios (HR) of current values of haemoglobin using a cause-specific Cox model adjusted for current values of glomerular filtration rate and transferrin saturation. All current values of biomarkers were first estimated in a multivariate-shared random effect joint model.

Results

Analyses considered 29 042 haemoglobin measurements from 2791 patients, and 364 MACE+. The association between current haemoglobin and log hazard of MACE+ was linear in men and J-shaped in women. For a haemoglobin of 10.5 g/dL, as compared with 11.5 g/dL, the hazard of MACE+ at any time was increased by 60% in younger women [HR = 1.6, 95% confidence interval (CI) 1.1–2.4], 70% in older women (HR = 1.7, 95% CI 1.3–2.4), 30% in younger men (HR = 1.3 95% CI 1.1–1.5) and 20% in older men (HR = 1.2 95% CI 1.1–1.4). Results were similar in the sensitivity analysis not censoring at the first ESA treatment.

Conclusion

Our longitudinal analysis in patients with CKD not on ESA therapy highlights a stronger association between anaemia and increased hazard of MACE+ in women than in men. This sex difference should inform the design of trials addressing anaemia correction in CKD.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

HemoglobinsCardiovascular DiseasesRenal Insufficiency, ChronicAnemiaBiomarkersHumansFemaleMaleAgedLongitudinal StudiesMiddle AgedGlomerular Filtration RateFollow-Up StudiesPrognosisRisk Factors

Stichwörter der Autor:innen

age and sex specificityanaemiahaemoglobinlongitudinal associationmajor adverse cardiovascular event

Substanzen

HemoglobinsBiomarkers

Autor:innen und Institutionen

  • Univ. Bordeaux, INSERM, BPH, U1219, CIC 1401, F-33000 Bordeaux, France.
  • Centre for Research in Epidemiology and Population Health, Paris-Saclay University, Inserm U1018, Versailles Saint-Quentin University, Clinical Epidemiology Team, Villejuif, France.
  • Bordeaux University Hospital, Pediatric Nephrology Unit, Centre de Référence des Maladies Rénales Rares Sorare, Pellegrin-Enfants Hospital, Bordeaux, France.
  • Department of Nephrology, Centre Hopitalier Lyon Sud, Lyon, France.
  • Centre Hospitalier d'Ardèche Méridionale, Aubenas, France.
  • Amiens Picardie University Hospital, Department of Nephrology Dialysis Transplantation, Amiens, France.

ORCID-Profile: Natalia Alencar de Pinho, Christian Combe, Sophie Liabeuf, Ziad A Massy

Förderung

  • Agence Nationale de la Recherche
  • GlaxoSmithKline
  • Boehringer Ingelheim France
  • Otsuka Pharmaceutical
  • AstraZeneca
  • EHESP

Zitieren

APA

Le Gall, L., Alencar de Pinho, N., Harambat, J., Combe, C., Drüeke, T. B., Choukroun, G., Fouque, D., Barbieri, A., Frimat, L., Jacquelinet, C., Laville, M., Liabeuf, S., Pecoits-Filho, R., Philipps, V., Massy, Z. A., Stengel, B., Prezelin-Reydit, M., Leffondré, K., & CKD-REIN study group (2025). A longitudinal analysis of haemoglobin levels and major cardiovascular events. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfaf221

Vancouver

Le Gall L, Alencar de Pinho N, Harambat J, Combe C, Drüeke TB, Choukroun G, et al. A longitudinal analysis of haemoglobin levels and major cardiovascular events. Nephrology Dialysis Transplantation. 2025. doi:10.1093/ndt/gfaf221

BibTeX
@article{LeGall2025,
  author = {Le Gall, Lisa and Alencar de Pinho, Natalia and Harambat, Jérôme and Combe, Christian and Drüeke, Tilman B and Choukroun, Gabriel and Fouque, Denis and Barbieri, Antoine and Frimat, Luc and Jacquelinet, Christian and Laville, Maurice and Liabeuf, Sophie and Pecoits-Filho, Roberto and Philipps, Viviane and Massy, Ziad A and Stengel, Bénédicte and Prezelin-Reydit, Mathilde and Leffondré, Karen and CKD-REIN study group, CKD-REIN study group},
  title = {A longitudinal analysis of haemoglobin levels and major cardiovascular events},
  journal = {Nephrology Dialysis Transplantation},
  year = {2025},
  doi = {10.1093/ndt/gfaf221}
}
Kostenlos starten →